Veru (VERU)
(Delayed Data from NSDQ)
$0.78 USD
-0.02 (-2.67%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $0.78 0.00 (0.03%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth B Momentum C VGM
Price, Consensus and EPS Surprise
VERU 0.78 -0.02(-2.67%)
Will VERU be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for VERU based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for VERU
Veru Inc. (VERU) Reports Q3 Loss, Tops Revenue Estimates
Capricor Therapeutics (CAPR) Reports Q2 Loss, Misses Revenue Estimates
VERU: What are Zacks experts saying now?
Zacks Private Portfolio Services
Veru Inc. (VERU) Just Flashed Golden Cross Signal: Do You Buy?
Baxter (BAX) to Report Q1 Earnings: What's in the Cards?
What Makes Veru (VERU) a New Buy Stock
Other News for VERU
Veru to Present at the 2024 Cantor Global Healthcare Conference
Warning: VERU is at high risk of performing badly
Analysts Offer Insights on Healthcare Companies: Veru (VERU) and ACADIA Pharmaceuticals (ACAD)
Veru Inc. (VERU) Q3 2024 Earnings Call Transcript
Oppenheimer Keeps Their Buy Rating on Veru (VERU)